Amalgamation of Nanotechnology for Delivery of Bioactive Constituents in Solid Tumors

Rabea Parveen1,2, Sradhanjali Mohapatra2, Sayeed Ahmad2

  • 1Department of Biosciences, Human Genetics Laboratory, Jamia Millia Islamia, New Delhi-110025, India.

Current Drug Delivery
|April 26, 2022
PubMed

Insights

Nanotechnology enhances phytochemicals for solid tumor treatment by improving drug delivery and reducing side effects. This approach offers a promising strategy for overcoming limitations of traditional cancer therapies.

Area of Science:

  • Oncology and Nanomedicine: Focuses on the intersection of cancer treatment and nanotechnology for solid tumors.

Background:

  • Solid tumors present treatment challenges due to drug resistance and poor drug penetration caused by tumor microenvironment heterogeneity.
  • Phytochemicals show promise as anticancer agents but face limitations like poor bioavailability, stability, and target specificity.
  • Existing treatments are often hampered by side effects and limited efficacy, necessitating novel therapeutic strategies.

Approach:

  • This review explores nanocarrier systems as a strategy to deliver bioactive phytochemicals for solid tumor management.
  • It discusses various plants and their constituents with anticancer potential, detailing their mechanisms of action.
  • Various nanocarrier systems employed for delivering these phytoconstituents are also enumerated.

Key Points:

  • Nanocarrier systems can potentiate the action of plant-derived compounds, improving efficacy and reducing side effects.
  • Nanosystems enable targeted delivery of phytochemicals to tumor sites, enhancing cellular uptake and retention.
  • Nanoparticles offer differential absorption, increasing efficacy in diseased tissues while minimizing toxicity to normal cells.

Conclusions:

  • Nanotechnology presents a valuable platform for developing effective phytomedicines for solid tumor prevention and treatment.
  • Targeted delivery via nanocarriers overcomes phytochemical limitations, paving the way for improved cancer therapies.
  • Further research into nanotechnology-based approaches is crucial for advancing solid tumor management.

Related Concept Videos